Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017–2022Research in context

Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017–2022Research in context

Summary: Background: With the growing notion of patient-focused drug development, the quality of life and other patient-reported outcomes (PROs) of cancer patients are gaining considerable attention. Several drug regulatory agencies, including the U.S. Food and Drug Administration (FDA), are callin...

Full description

Bibliographic Details
Main Authors: Chenghao Ge, Kaiyuan Guo, Yi Li, Guanqiao Li, Hong Zhang, Jiaxuan Yang, Yang Liu, Chen Yin, Sen Liu, Songmei Xie, Xiaoyuan Chen
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:EClinicalMedicine
Subjects:
Patient-reported outcome
Novel oncology drug
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702300130X

Internet

http://www.sciencedirect.com/science/article/pii/S258953702300130X

Similar Items